Pharmacoeconomics: from theory to practice
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Boca Raton [u.a.]
CRC Press
2010
|
| Schriftenreihe: | Drug discovery series
13 |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis Klappentext |
| Beschreibung: | Includes bibliographical references and index |
| Beschreibung: | XIV, 243 S. Ill., graph. Darst. |
| ISBN: | 9781420084221 |
Internformat
MARC
| LEADER | 00000nam a2200000zcb4500 | ||
|---|---|---|---|
| 001 | BV035858536 | ||
| 003 | DE-604 | ||
| 005 | 20100226 | ||
| 007 | t | ||
| 008 | 091203s2010 xxuad|| |||| 00||| eng d | ||
| 010 | |a 2009032763 | ||
| 020 | |a 9781420084221 |c hardcover : alk. paper |9 978-1-4200-8422-1 | ||
| 035 | |a (OCoLC)690806458 | ||
| 035 | |a (DE-599)GBV60758193X | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 044 | |a xxu |c US | ||
| 049 | |a DE-703 | ||
| 050 | 0 | |a RS100 | |
| 082 | 0 | |a 338.4/76151 | |
| 084 | |a QR 525 |0 (DE-625)142044: |2 rvk | ||
| 245 | 1 | 0 | |a Pharmacoeconomics |b from theory to practice |c ed. by Renee J. G. Arnold |
| 264 | 1 | |a Boca Raton [u.a.] |b CRC Press |c 2010 | |
| 300 | |a XIV, 243 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 1 | |a Drug discovery series |v 13 | |
| 500 | |a Includes bibliographical references and index | ||
| 650 | 4 | |a Médicaments - Coût-efficacité | |
| 650 | 4 | |a Pharmacie - Aspect économique | |
| 650 | 4 | |a Prise de décision | |
| 650 | 4 | |a Drugs |x Cost effectiveness | |
| 650 | 4 | |a Pharmacy |x Economic aspects | |
| 650 | 4 | |a Decision making | |
| 650 | 4 | |a Economics, Pharmaceutical | |
| 650 | 4 | |a Costs and Cost Analysis | |
| 650 | 4 | |a Decision Making | |
| 650 | 4 | |a Outcome Assessment (Health Care) |x economics | |
| 650 | 0 | 7 | |a Pharmakotherapie |0 (DE-588)4076066-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Pharmakotherapie |0 (DE-588)4076066-2 |D s |
| 689 | 0 | 1 | |a Kosten-Nutzen-Analyse |0 (DE-588)4032589-1 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Arnold, Renée J. G. |e Sonstige |0 (DE-588)139675620 |4 oth | |
| 830 | 0 | |a Drug discovery series |v 13 |w (DE-604)BV021489525 |9 13 | |
| 856 | 4 | 2 | |m LoC Fremddatenuebernahme |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018716439&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 856 | 4 | 2 | |m Digitalisierung UB Bayreuth |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018716439&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |3 Klappentext |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-018716439 | ||
Datensatz im Suchindex
| _version_ | 1804140836314677248 |
|---|---|
| adam_text | PHARMACOECONOMICS
/ ARNOLD, RENEE J. G.
: 2010
TABLE OF CONTENTS / INHALTSVERZEICHNIS
INTRODUCTION TO PHARMACOECONOMICS / WILLIAM F. MCGHAN
DECISION MODELING TECHNIQUES / MARK S. ROBERTS AND KEN SMITH
COST OF ILLNESS / RENEE J.G. ARNOLD
MARKOV MODELING IN DECISION ANALYSIS / J. ROBERT BECK
RETROSPECTIVE DATABASE ANALYSIS / RENEE J.G. ARNOLD AND SANJEEV BALU
WHAT IS COST-MINIMIZATION ANALYSIS? / ALAN HAYCOX
COST-EFFECTIVENESS ANALYSIS / KENNETH J. SMITH AND MARK S. ROBERTS
BUDGET IMPACT ANALYSIS / LIEVEN ANNEMANS
COST-UTILITY ANALYSIS : A CASE STUDY OF A QUADRIVALENT HUMAN
PAPILLOMAVIRUS VACCINE / ERIK J. DASBACH, RALPH P. INSINGA, AND ELAMIN
H. ELBASHA
SOME PROBLEMS/ASSUMPTIONS IN PHARMACOECONOMIC ANALYSIS / STUART BIRKS
PATIENT-REPORTED OUTCOME MEASURES / DIANNE BRYANT, GORDON GUYATT, AND
RENEE J.G. ARNOLD
SENSITIVITY ANALYSIS / MAARTEN J. POSTMA
USE OF PHARMACOECONOMICS IN DRUG REIMBURSEMENT IN AUSTRALIA, CANADA, AND
THE UNITED KINGDOM : WHAT CAN WE LEARN FROM INTERNATIONAL EXPERIENCE? /
MICHAEL DRUMMOND AND CORINNA SORENSON
PHARMACOECONOMICS IN DISEASE MANAGEMENT : PRACTICAL APPLICATIONS AND
PERSISTENT CHALLENGES / RYUNG SUH AND DAVID ATKINS
COMPUTER AIDED DECISION MAKING FROM DRUG DISCOVERY TO PHARMACOECONOMICS
/ SEAN EKINS AND RENEE J.G. ARNOLD
SPECULATIONS ON THE FUTURE CHALLENGES AND VALUE OF PHARMACOECONOMICS /
J. JAIME CARO, DENIS GETSIOS, AND RACHAEL L. FLEURENCE.
DIESES SCHRIFTSTUECK WURDE MASCHINELL ERZEUGT.
Pharmacology and Toxicology
PHARMACOECONOMICS
From Theory to Practice
The pharmaceutical industry is almost boundless in its ability to supply
new drug therapies, but how does one decide which are the best
medicines to use within restricted budgets? With particular emphasis
on modeling, methodologies, data sources, and application to real-
world dilemmas, Pharmacoeconomics: From Theory to Practice
provides an introduction to the major concepts and principles of
pharmacoeconomics and cost-effectiveness analysis
(CEA).
As a running theme, the book explores the collaboration among
members of the pharmaceutical industry,
academia,
and government
in the development of the human papillomavirus vaccine to demonstrate
the full range of ethical and moral issues, as well as overall public
health and commercial concerns that are often involved in decisions
entailing
CEA.
Readers will learn about the international use of
pharmacoeconomics in drug regulation, drug approval, and pricing,
and the book provides examples of pharmacoeconomic models used
to support these purposes in government, the pharmaceutical industry,
and healthcare settings.
In this era of finite budgets, healthcare rationing, medication shortages,
and the global aging and burgeoning of populations, numerous
stakeholders in the healthcare arena must understand the basic
principles of pharmacoeconomics and how these may be correctly
applied to facilitate drug development, drug approval, rationing, patient
segmentation, disease management, and pricing model development.
Focusing on how to save money, not by restricting access to necessary
services, but by using available resources more efficiently and rationally,
this volume arms decision makers with the tools they need to make
wise choices in an area where the stakes are so high.
ачѕѕч
ΓΌΓ
Drace
і
«»0
Broto,
Sound P.*«*
NW
CKL
ГГеЅЅ
I Suite
300,
Boca Raton, FL 334«7
Taylor
&
Francis Croup
! 270
Madison Avenue
an
Monna
business
j
New York, NY
10016
www.crcpress.com
|
| any_adam_object | 1 |
| author_GND | (DE-588)139675620 |
| building | Verbundindex |
| bvnumber | BV035858536 |
| callnumber-first | R - Medicine |
| callnumber-label | RS100 |
| callnumber-raw | RS100 |
| callnumber-search | RS100 |
| callnumber-sort | RS 3100 |
| callnumber-subject | RS - Pharmacy |
| classification_rvk | QR 525 |
| ctrlnum | (OCoLC)690806458 (DE-599)GBV60758193X |
| dewey-full | 338.4/76151 |
| dewey-hundreds | 300 - Social sciences |
| dewey-ones | 338 - Production |
| dewey-raw | 338.4/76151 |
| dewey-search | 338.4/76151 |
| dewey-sort | 3338.4 576151 |
| dewey-tens | 330 - Economics |
| discipline | Wirtschaftswissenschaften |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02300nam a2200553zcb4500</leader><controlfield tag="001">BV035858536</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20100226 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">091203s2010 xxuad|| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2009032763</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781420084221</subfield><subfield code="c">hardcover : alk. paper</subfield><subfield code="9">978-1-4200-8422-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)690806458</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)GBV60758193X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-703</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RS100</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">338.4/76151</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QR 525</subfield><subfield code="0">(DE-625)142044:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacoeconomics</subfield><subfield code="b">from theory to practice</subfield><subfield code="c">ed. by Renee J. G. Arnold</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boca Raton [u.a.]</subfield><subfield code="b">CRC Press</subfield><subfield code="c">2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIV, 243 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Drug discovery series</subfield><subfield code="v">13</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Médicaments - Coût-efficacité</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacie - Aspect économique</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Prise de décision</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drugs</subfield><subfield code="x">Cost effectiveness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmacy</subfield><subfield code="x">Economic aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Decision making</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Economics, Pharmaceutical</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Costs and Cost Analysis</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Decision Making</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Outcome Assessment (Health Care)</subfield><subfield code="x">economics</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmakotherapie</subfield><subfield code="0">(DE-588)4076066-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Kosten-Nutzen-Analyse</subfield><subfield code="0">(DE-588)4032589-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Arnold, Renée J. G.</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)139675620</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Drug discovery series</subfield><subfield code="v">13</subfield><subfield code="w">(DE-604)BV021489525</subfield><subfield code="9">13</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">LoC Fremddatenuebernahme</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018716439&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Bayreuth</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018716439&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Klappentext</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-018716439</subfield></datafield></record></collection> |
| id | DE-604.BV035858536 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T22:06:18Z |
| institution | BVB |
| isbn | 9781420084221 |
| language | English |
| lccn | 2009032763 |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-018716439 |
| oclc_num | 690806458 |
| open_access_boolean | |
| owner | DE-703 |
| owner_facet | DE-703 |
| physical | XIV, 243 S. Ill., graph. Darst. |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | CRC Press |
| record_format | marc |
| series | Drug discovery series |
| series2 | Drug discovery series |
| spelling | Pharmacoeconomics from theory to practice ed. by Renee J. G. Arnold Boca Raton [u.a.] CRC Press 2010 XIV, 243 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Drug discovery series 13 Includes bibliographical references and index Médicaments - Coût-efficacité Pharmacie - Aspect économique Prise de décision Drugs Cost effectiveness Pharmacy Economic aspects Decision making Economics, Pharmaceutical Costs and Cost Analysis Decision Making Outcome Assessment (Health Care) economics Pharmakotherapie (DE-588)4076066-2 gnd rswk-swf Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd rswk-swf Pharmakotherapie (DE-588)4076066-2 s Kosten-Nutzen-Analyse (DE-588)4032589-1 s DE-604 Arnold, Renée J. G. Sonstige (DE-588)139675620 oth Drug discovery series 13 (DE-604)BV021489525 13 LoC Fremddatenuebernahme application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018716439&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis Digitalisierung UB Bayreuth application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018716439&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA Klappentext |
| spellingShingle | Pharmacoeconomics from theory to practice Drug discovery series Médicaments - Coût-efficacité Pharmacie - Aspect économique Prise de décision Drugs Cost effectiveness Pharmacy Economic aspects Decision making Economics, Pharmaceutical Costs and Cost Analysis Decision Making Outcome Assessment (Health Care) economics Pharmakotherapie (DE-588)4076066-2 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd |
| subject_GND | (DE-588)4076066-2 (DE-588)4032589-1 |
| title | Pharmacoeconomics from theory to practice |
| title_auth | Pharmacoeconomics from theory to practice |
| title_exact_search | Pharmacoeconomics from theory to practice |
| title_full | Pharmacoeconomics from theory to practice ed. by Renee J. G. Arnold |
| title_fullStr | Pharmacoeconomics from theory to practice ed. by Renee J. G. Arnold |
| title_full_unstemmed | Pharmacoeconomics from theory to practice ed. by Renee J. G. Arnold |
| title_short | Pharmacoeconomics |
| title_sort | pharmacoeconomics from theory to practice |
| title_sub | from theory to practice |
| topic | Médicaments - Coût-efficacité Pharmacie - Aspect économique Prise de décision Drugs Cost effectiveness Pharmacy Economic aspects Decision making Economics, Pharmaceutical Costs and Cost Analysis Decision Making Outcome Assessment (Health Care) economics Pharmakotherapie (DE-588)4076066-2 gnd Kosten-Nutzen-Analyse (DE-588)4032589-1 gnd |
| topic_facet | Médicaments - Coût-efficacité Pharmacie - Aspect économique Prise de décision Drugs Cost effectiveness Pharmacy Economic aspects Decision making Economics, Pharmaceutical Costs and Cost Analysis Decision Making Outcome Assessment (Health Care) economics Pharmakotherapie Kosten-Nutzen-Analyse |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018716439&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=018716439&sequence=000004&line_number=0002&func_code=DB_RECORDS&service_type=MEDIA |
| volume_link | (DE-604)BV021489525 |
| work_keys_str_mv | AT arnoldreneejg pharmacoeconomicsfromtheorytopractice |